Upregulation of β3-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium

Circulation

Volumn 103, Issue 12, 2001, Pages 1649-1655

  Moniotte, Stéphane ^a,b,c,d   Kobzik, Lester ^a,b,c,d   Feron, Olivier ^a,b,c,d   Trochu, Jean Noël ^a,b,c,d   Gauthier, Chantal ^a,b,c,d   Balligand, Jean Luc ^a,b,c,d  

^a UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

^b INSERM   (France)

^c UNIVERSITÉ DE NANTES   (France)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Catecholamines; Contractility; Heart failure; Nitric oxide synthase; Receptors, adrenergic, beta

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INOTROPISM; MALE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; WESTERN BLOTTING;

EID: 0035957302     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.12.1649     Document Type: Article

References (35)

1. β1- and β2-adrenergic receptor-mediated adenylate cyclase stimulation in non-failing and failing human ventricular myocardium
2. Inhibition of β-adrenergic receptor kinase prevents rapid homologous desensitization of β2-adrenergic receptors
3. β1- and β2-adrenoceptors in the human heart: Properties, function, and alterations in chronic heart failure
4. Reduced β1-receptor messenger RNA abundance in the failing human heart
5. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts
6. Analysis of β-adrenergic receptor mRNA levels in human ventricular biopsy specimens by quantitative polymerase chain reactions: Progressive reduction of β1-adrenergic receptor mRNA in heart failure
7. Changes in gene expression in the intact human heart: Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium
8. Altered expression of β-adrenergic receptor kinase and β1- adrenergic receptors in the failing human heart
9. Increased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failure
10. Altered expression of alpha-subunits of G proteins in failing human hearts
11. Radioimmunochemical quantification of Gi alpha in right and left ventricles from patients with ischaemic and dilated cardiomyopathy and predominant left ventricular failure
12. Enhanced myocardial function in transgenic mice overexpressing the β2-adrenergic receptor
13. Adverse effects of chronic endogenous sympathetic drive induced by cardiac Gs alpha overexpression
14. Restoration of β-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer
15. Progressive hypertrophy and heart failure in β1-adrenergic receptor transgenic mice
16. The molecular basis for distinct β-adrenergic receptor subtype actions in cardiomyocytes
17. β-adrenergic receptor blockade in chronic heart failure
18. Molecular characterization of the human β3-adrenergic receptor
19. Tissue distribution of β3-adrenergic receptor mRNA in man
20. Functional β3-adrenoceptor in the human heart
21. The negative inotropic effect of β3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle
22. Structural basis for receptor subtype-specific regulation revealed by a chimeric β3/β2-adrenergic receptor
23. 36B4 cDNA used as an estradio-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO
24. Endomyocardial biopsies: A new approach for studying the electrical and mechanical properties of human ventricular myocardium
25. The tissue distribution of the human β3-adrenoceptor studied using a monoclonal antibody: Direct evidence of the β3-adrenoceptor in human adipose tissue, atrium and skeletal muscle
26. Interspecies differences in the cardiac negative inotropic effects of β3-adrenoceptor agonists
27. β3-adrenoceptors in the cardiovascular system
28. Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart
29. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system
30. Inhibition of nitric oxide synthase augments myocardial contractile responses to β-adrenergic stimulation
31. Nitric oxide inhibits the positive inotropic response to β-adrenergic stimulation in humans with left ventricular dysfunction
32. Modulation of mouse cardiac function in vivo by eNOS and ANP
33. Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: Potentiation of β-adrenergic inotropic responsiveness
34. β3-Adrenoceptor deficiency blocks nitric oxide-dependent inhibition of myocardial contractility
35. Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy